Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

May 31, 2020

Conditions
Hypercholesterolemia
Interventions
DRUG

Rosuvastatin and Ezetimibe morning or evening administration

"Timing of the drug administration:~morning -\> evening evening -\> morning"

Trial Locations (1)

85-094

Cardiology Department, Dr. A. Jurasz University Hospital, Bydgoszcz

All Listed Sponsors
lead

Collegium Medicum w Bydgoszczy

OTHER

NCT02772640 - Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe | Biotech Hunter | Biotech Hunter